Filing Flows › InnovAge Holding (INNV) › Guidance & outlook
InnovAge Holding (INNV) guidance and outlook
InnovAge Holding (INNV) reaffirmed its guidance on Nov 3, 2026: Revenue $1.1B for FY2027; EBITDA −$2.0M for FY2027. InnovAge Holding's 10-Q filed Nov 3, 2026 makes 25 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2027 | $1.1B | reaffirmed |
| EBITDA | FY2027 | −$2.0M | reaffirmed |
From the earnings release filed Nov 3, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 3, 2026
- Once the process is complete, which we expect to be during the second fiscal quarter, these ACS centers will provide our participants with flexibility to participate in activities and receive certain services.
- We anticipate increased cost from our third-party service providers beginning in the second half of fiscal year 2027, or the first half of calendar year 2027, as providers seek to offset heightened expenses resulting, in part, from budget pressures associated with the Reconciliation Act, budget cuts to providers from state Medicaid programs, as well as possible increases in other costs in order to provide…
- We did not experience a material increase to our cost of care and external provider costs during the first quarter of fiscal year 2027 and do not anticipate a material increase in the second quarter.
- We continue to believe that our ongoing clinical and operational value initiatives may assist us in reducing unnecessary utilization and offsetting the increased costs anticipated in the later part of fiscal year 2027.
- In Colorado, where we serve the largest cohort of our PACE census, we anticipate a decrease in Medicaid premium rates,
- We also expect to face Medicaid reimbursement wage pressures from other states that release rates effective January 1, 2027, such as California, which could impact the latter half of our fiscal year.
- As a result, while we have not experienced any material impacts during the first quarter, we continue to expect the rate pressures to impact the Company's margins in fiscal 2027 and continue to monitor the full effects of the Reconciliation Act on the Company.
- Our historical financial performance has been, and we expect our financial performance in the future to be, driven by the following factors:
- As we serve more participants in existing centers, we expect to leverage our fixed cost base at those centers and increase the value of a center to our business over time.
- We also have pursued and intend to continue pursuing additional relationships with key stakeholders, existing organizations and other care providers in order to form partnerships in target geographies.
- We intend to continue investing in our centers, value-based care model, and sales and marketing initiatives to support long-term growth.
- We expect our expenses to increase in absolute dollars for the foreseeable future to support our growth and as the result of current and potential legal and regulatory proceedings.
InnovAge Holding's latest quarter
InnovAge Holding, Q1 FY27: revenue $265M (+12% year over year), operating margin 7.6%, net earnings $19.6M, operating cash flow $28.7M. The chart follows the revenue to costs, profit and cash.
Questions
Did InnovAge Holding raise or lower its guidance?
InnovAge Holding (INNV) reaffirmed its guidance on Nov 3, 2026: Revenue $1.1B for FY2027; EBITDA −$2.0M for FY2027.
What does InnovAge Holding expect?
Once the process is complete, which we expect to be during the second fiscal quarter, these ACS centers will provide our participants with flexibility to participate in activities and receive certain services. We anticipate increased cost from our third-party service providers beginning in the second half of fiscal year 2027, or the first half of calendar year 2027, as providers seek to offset heightened expenses resulting, in part, from budget pressures associated with the Reconciliation Act, budget cuts to providers from state Medicaid programs, as well as possible increases in other costs i
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.